What is the evidence for tenoxicam injections in the treatment of subacromial impingement syndrome?
Summary
Patient Population:
Single study identified: n=80. All patients had rotator cuff tendonitis.
Intervention:
Tenoxicam (20mg/2mL) once a week for up to 4 weeks.
Comparison:
It appears that they included 3 reviews and an additional 5 RCTs that did not appear in any of those 3 reviews. From within the identified reviews, they included information from 11, 9 and 7 trials. Tables are provided reporting the information abstracted from each trial in the categories corresponding to where they were found.
Outcome:
-
Pain: One low-quality RCT demonstrated significant improvement in terms of pain at rest and during active movement in favour of injection vs. placebo. Significant improvements associated with injection (vs. placebo) were also reported in terms of shoulder mobility.